GIS Tank-Type Surge Arrester Market Insight, Size, Share, Growth, Up-To-Date Key Trends, Regional Outlook, and Forecast - 2030
Price : US$ 3,000 | Date : Jul 2023 |
Category : Energy, Mining and Utilities | Pages : 133 |
The Human Immunodeficiency Virus Type-1 (HIV-1) Market is set to witness immense growth during the forecast period 2022-2028. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers/players/vendors analysis, segments & sub-segments, and forecast. The report also focuses on market drivers, challenges (current and future), revenue growth, future roadmap, standardization, deployment models, and forecast analysis.
Overview:
Human immunodeficiency virus is a viral infection that causes a progressive breakdown of the immune system, leading to life-threatening infections and cancer. There are two species of human immunodeficiency virus. The human immunodeficiency virus causes acquired immunodeficiency syndrome, a condition in which the immune system is weakened and can no longer fight off harmful infections and cancers. HIV infects the cells of the immune system, including helper T cells, macrophages, and dendritic cells. When the virus infects these cells, it causes the CD4+ T cell count to drop, as well as the death of T cells and other immune cells. Infected cells also lose cell-mediated immunity, leading to AIDS. Once inside the human cell, HIV releases RNA. This RNA then gets replicated by an enzyme known as reverse transcriptase. The resulting DNA copy is incorporated into the infected cell's DNA. The reverse replication process of HIV makes it unique among RNA viruses.
The global human immunodeficiency virus type-1 (HIV-1) market focuses on six regions, such as North America, Asia Pacific, South America, Europe, the Middle East, and Africa.
Drivers:
Increasing incidence of HIV in the world is expected to fuel the growth of the global human immunodeficiency virus type-1 (HIV-1) market over the forecast period. For instance, according to the World Health Organization, there are 38.4 million individuals in the world who are living with HIV. During the primary phase of infection, HIV may not cause any noticeable symptoms. HIV can live undetected in the body for years. In this phase, the virus can hide in white blood cells and remain undetected. When it reactivates in the future, it can make the person sick again. The CD4 cell count is one of the most important tests to monitor the progression of the disease and determine the appropriate treatment. If the CD4 cell count falls below 200, the infection is considered advanced. A lower CD4 cell count also puts the person at higher risk for opportunistic infections. Moreover, the increasing treatment advancements are estimated to enhance the growth of the global human immunodeficiency virus type-1 (HIV-1) market.
Restraints:
The negative stigma regarding HIV is expected to hinder the growth of the global human immunodeficiency virus type-1 (HIV-1) market.
Regional Insights:
In regions, North America is expected to witness significant growth in the global human immunodeficiency virus type-1 (HIV-1) market owing to the high prevalence of HIV in the region. For instance, according to HIV.gov, in 2019, there were around 1.2 million individuals living in the US, who are diagnosed with HIV. Moreover, the Asia Pacific is estimated to witness high growth in the global human immunodeficiency virus type-1 (HIV-1) market, owing to less awareness regarding sanitation and hygiene among several individuals in the region, along with the increasing investments in research and developments related to HIV treatments.
Competitive Section:
Key players operating in the global human immunodeficiency virus type-1 (HIV-1) market include ViiV Healthcare, United Biopharma, Theratechnologies Inc., TaiMed Biologics Inc., Sanofi, National Institute of Allergy and Infectious Diseases, Mylan Laboratories Limited, Merck Sharp & Dohme Corp, Merck, Janssen Pharmaceuticals, GlaxoSmithKline, Gilead Sciences, Inc., Frontier Biotechnologies, CytoDyn, and Aelix Therapeutics.
Human Immunodeficiency Virus Type-1 (HIV-1) Market Dynamics:
This market study estimates the market size in terms of both value (million USD) and volume (K Units). The Human Immunodeficiency Virus Type-1 (HIV-1) Market report analyses market trends based on historical data and the latest developments. It provides both qualitative and quantitative data on the elements that will shape the market's growth from 2022 to 2028. The market capacity and consumption potential of major companies are discussed in this research report. Furthermore, it concentrates on prominent regions (Latin America, Europe, Asia Pacific, Africa, and the Middle East). Also, the report evaluates COVID-19's impact on the Human Immunodeficiency Virus Type-1 (HIV-1) Market.
Companies profiled in the Human Immunodeficiency Virus Type-1 (HIV-1) Market report include:
The report covers extensive competitive intelligence which includes the following data points:
⇨ Business Overview
⇨ Business Model
⇨ Financial Data
⇨ Financial – Existing
⇨ Financial – Funding
⇨ Product/Service Segment Analysis and specification
⇨ Recent Development and Company Strategy Analysis
⇨ SWOT Analysis
Segmentation by Type:
The type segment contributed the largest share to the Human Immunodeficiency Virus Type-1 (HIV-1) Market in 2021; this segment is projected to grow at the highest CAGR from 2022 to 2028.
Segmentation by Application:
An end-use industry is projected to grow at the highest CAGR during the forecast period, due to rapid development in emerging economies North America, APAC, MEA, Europe, and ROW.
Key Benefits for Stakeholders:
Reasons to Purchase Human Immunodeficiency Virus Type-1 (HIV-1) Market Report:
Research Methodology:
To estimate and validate the size of the Human Immunodeficiency Virus Type-1 (HIV-1) Market and many other dependent submarkets in the overall market, both top-down and bottom-up methodologies are utilized. Key players in the market have been identified through secondary research and their market shares have been determined through primary and secondary research. Secondary sources and verified primary sources were used to determine all percentage share splits and breakdowns.
* Browse 15 Market Data Tables and 32 Figures on “Human Immunodeficiency Virus Type-1 (HIV-1) Market Market” – Forecast to 2028.
Price : US$ 3,000 | Date : Jul 2023 |
Category : Energy, Mining and Utilities | Pages : 133 |
Price : US$ 3,000 | Date : Jul 2023 |
Category : Manufacturing and Construction | Pages : 123 |
Price : US$ 3,000 | Date : Jul 2023 |
Category : Services | Pages : 120 |
Price : US$ 3,000 | Date : Jun 2023 |
Category : Services | Pages : 101 |
Price : US$ 3,000 | Date : Jun 2023 |
Category : Healthcare and Pharmaceuticals | Pages : 198 |
In search of customized market research solution? We are here to help you. Contact us.